Prostate cancer recurrence after Focal Therapy: Treatment options

Area of Science:

• Oncology
• Urology

Background:

• Focal therapy is an emerging treatment for localized prostate cancer, particularly for low to intermediate risk cases.
• It offers favorable short to medium-term outcomes with reduced genitourinary side effects compared to radical treatments.
• Focal therapy is increasingly chosen by patients who find radical options or active surveillance unsuitable.

Purpose of the Study:

• To review existing literature on treatment strategies for prostate cancer recurrence following focal therapy.
• To discuss established definitions of treatment failure after focal therapy.
• To explore the implications of these definitions for the future management of patients.

Main Methods:

• Comprehensive literature review of studies on prostate cancer recurrence post-focal therapy.
• Analysis of consensus meeting reports defining focal therapy failure.
• Discussion of management implications based on reviewed literature and definitions.

Main Results:

• Focal therapy demonstrates good short to medium-term outcomes for localized prostate cancer.
• Reduced genitourinary side effects make it an attractive alternative to radical treatments or active surveillance.
• Literature on post-focal therapy recurrence management is evolving, with defined failure criteria impacting patient care.

Conclusions:

• Focal therapy is a viable option for selected prostate cancer patients, offering a balance between efficacy and quality of life.
• Understanding and applying standardized definitions of failure are crucial for effective post-treatment surveillance and management.
• Further research is needed to optimize long-term outcomes and refine retreatment strategies for recurrent prostate cancer after focal therapy.